Literature DB >> 32799361

Host-parasite dynamics in Chagas disease from systemic to hyper-local scales.

Damián Pérez-Mazliah1, Alexander I Ward2, Michael D Lewis2.   

Abstract

Trypanosoma cruzi is a remarkably versatile parasite. It can parasitize almost any nucleated cell type and naturally infects hundreds of mammal species across much of the Americas. In humans, it is the cause of Chagas disease, a set of mainly chronic conditions predominantly affecting the heart and gastrointestinal tract, which can progress to become life threatening. Yet around two thirds of infected people are long-term asymptomatic carriers. Clinical outcomes depend on many factors, but the central determinant is the nature of the host-parasite interactions that play out over the years of chronic infection in diverse tissue environments. In this review, we aim to integrate recent developments in the understanding of the spatial and temporal dynamics of T. cruzi infections with established and emerging concepts in host immune responses in the corresponding phases and tissues.
© 2020 The Authors. Parasite Immunology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Chagas disease; cell mediated immunity; humoral immunity; in vivo imaging; innate immunity; trypanosomes

Mesh:

Substances:

Year:  2020        PMID: 32799361     DOI: 10.1111/pim.12786

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  5 in total

1.  7-Aryl-7-deazapurine 3'-deoxyribonucleoside derivative as a novel lead for Chagas' disease therapy: in vitro and in vivo pharmacology.

Authors:  Camila Cardoso-Santos; Ludmila Ferreira de Almeida Fiuza; Cristiane França da Silva; Ana Lia Mazzeti; Roberson Donola Girão; Gabriel Melo de Oliveira; Denise da Gama Jaen Batista; Otacilio Cruz Moreira; Natália Lins da Silva Gomes; Louis Maes; Guy Caljon; Fabian Hulpia; Serge V Calenbergh; Maria de Nazaré Correia Soeiro
Journal:  JAC Antimicrob Resist       Date:  2021-11-17

2.  Incomplete Recruitment of Protective T Cells Is Associated with Trypanosoma cruzi Persistence in the Mouse Colon.

Authors:  Alexander I Ward; Michael D Lewis; Martin C Taylor; John M Kelly
Journal:  Infect Immun       Date:  2021-11-15       Impact factor: 3.441

3.  Sheltered in Stromal Tissue Cells, Trypanosoma cruzi Orchestrates Inflammatory Neovascularization via Activation of the Mast Cell Chymase Pathway.

Authors:  Lucas Vellasco; Erik Svensjö; Carlos Alberto Bulant; Pablo Javier Blanco; Fábio Nogueira; Gilberto Domont; Natália Pinto de Almeida; Clarissa Rodrigues Nascimento; Danielle Silva-Dos-Santos; Carla Eponina Carvalho-Pinto; Emiliano Horácio Medei; Igor C Almeida; Julio Scharfstein
Journal:  Pathogens       Date:  2022-01-29

4.  Hypoxia Effects on Trypanosoma cruzi Epimastigotes Proliferation, Differentiation, and Energy Metabolism.

Authors:  Francis M S Saraiva; Daniela Cosentino-Gomes; Job D F Inacio; Elmo E Almeida-Amaral; Orlando Louzada-Neto; Ana Rossini; Natália P Nogueira; José R Meyer-Fernandes; Marcia C Paes
Journal:  Pathogens       Date:  2022-08-09

5.  Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure.

Authors:  Amanda Fortes Francisco; Ursula Saade; Shiromani Jayawardhana; Hans Pottel; Ivan Scandale; Eric Chatelain; Peter Liehl; John M Kelly; Maan Zrein
Journal:  PLoS Negl Trop Dis       Date:  2022-10-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.